|
|
||||||||
Division of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, and The Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts
Correspondence: For reprints contact: G.N. Larar, PhD, Department of Radiology, Nassau County Medical Center, 2201 Hempstead Tumpike, East Meadow, NY 11554.
ABSTRACT
The lipophilic cerebral perfusion agent 99mTc-hexamethylpropylene amine oxime (HMPAO) is increasingly used to demonstrate the absence of blood flow for the declaration of brain death. We report a case that illustrates how the timing of such studies is important when organ harvesting is the undenying emergent indication. If performed too early, a study showing the presence of cerebral perfusion may not expedite the declaration of brain death, but instead may complicate patient assessment and unnecessarily delay the process.
This article has been cited by other articles:
![]() |
J-R Kuo, C-F Chen, C-C Chio, C-H Chang, C-C Wang, C-M Yang, and K-C Lin Time dependent validity in the diagnosis of brain death using transcranial Doppler sonography J. Neurol. Neurosurg. Psychiatry, May 1, 2006; 77(5): 646 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Newberg, A. Alavi, S. van Rhijn, A. Cotter, and P. Reilly Radiologic Diagnosis of Brain Death JAMA, November 6, 2002; 288(17): 2121 - 2122. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |